April 29th 2017

http://ift.tt/eA8V8J

The Medicines Company (NASDAQ:MDCO) – Equities researchers at Leerink Swann increased their Q2 2017 earnings per share (EPS) estimates for shares of The Medicines Company in a report released on Wednesday. Leerink Swann analyst J. Schwartz now expects …

Top 10 Most Anticipated AAA Games of …
A Massive Essential Store Now Continu…
How Long Does the Tapo C100 Store Vid…
Navigating Freelance Writing Jobs wit…

The post Leerink Swann Equities Analysts Raise Earnings Estimates for The Medicines Company (MDCO) appeared first on ForexTV.

April 29, 2017 at 11:26PM

http://ift.tt/2qqtqsP

from Equities News Editor

http://ift.tt/2qqtqsP

This post first appeared on Corporate Governance, please read the originial post: here